Stuart Hobbs

1.0k total citations
17 papers, 817 citations indexed

About

Stuart Hobbs is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Stuart Hobbs has authored 17 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Stuart Hobbs's work include HER2/EGFR in Cancer Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Stuart Hobbs is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Stuart Hobbs collaborates with scholars based in United States, United Kingdom and Germany. Stuart Hobbs's co-authors include D. Brent Polk, C. Viner, Alison Jones, Peter J. Selby, Hanwei Cao, Richard M. Peek, Yan Fang, Ronald W. Matheny, A. Hilary Calvert and Uma Krishna and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Stuart Hobbs

17 papers receiving 800 citations

Peers

Stuart Hobbs

IMMUN

SURGE

ONCOL

PRM

Kazuyoshi Yamauchi Japan

Christof Meischl Netherlands

Philip E. Dubé United States

S Satoh Japan

Sophie E. Broughton Australia

Xiaoming Zhang China

G. Kojouharoff Germany

Doris Vokurková Czechia

Júlia Varga Germany

Caroline Finlayson United Kingdom

Kazuyoshi Yamauchi Japan

Stuart Hobbs

335 ×1.2

139 ×0.6

IMMUN

280 ×1.2

SURGE

79 ×0.4

ONCOL

145 ×1.6

PRM

Citations per year, relative to Stuart Hobbs Stuart Hobbs (= 1×) peers Kazuyoshi Yamauchi

Countries citing papers authored by Stuart Hobbs

Since Specialization

Citations

This map shows the geographic impact of Stuart Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Hobbs more than expected).

Fields of papers citing papers by Stuart Hobbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Hobbs. The network helps show where Stuart Hobbs may publish in the future.

Co-authorship network of co-authors of Stuart Hobbs

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Hobbs. A scholar is included among the top collaborators of Stuart Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Hobbs. Stuart Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hobbs, Stuart, et al.. (2023). MyD88 and not TRIF knockout is sufficient to abolish LPS‐induced inflammatory responses in bone‐derived macrophages. FEBS Letters. 597(9). 1225–1232. 6 indexed citations

Hobbs, Stuart, et al.. (2018). LPS‐stimulatedNF‐κB p65 dynamic response marks the initiation ofTNFexpression and transition toIL‐10 expression inRAW264.7 macrophages. Physiological Reports. 6(21). e13914–e13914. 63 indexed citations

Mitrophanov, Alexander Y., et al.. (2017). NFkB activation and cytokine output in LPS‐treated RAW 264.7 macrophages. The FASEB Journal. 31(S1). 3 indexed citations

Matheny, Ronald W., et al.. (2016). RNA transcript expression of IGF-I/PI3K pathway components in regenerating skeletal muscle is sensitive to initial injury intensity. Growth Hormone & IGF Research. 32. 14–21. 18 indexed citations

Sierra, Johanna C., Stuart Hobbs, Rupesh Chaturvedi, et al.. (2013). Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 305(2). G196–G203. 31 indexed citations

McElroy, Steven J., Stuart Hobbs, Michael E. Kallen, et al.. (2012). Transactivation of EGFR by LPS Induces COX-2 Expression in Enterocytes. PLoS ONE. 7(5). e38373–e38373. 50 indexed citations

Hobbs, Stuart, Jeremy A. Goettel, Dongchun Liang, et al.. (2011). TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 301(2). G220–G229. 38 indexed citations

Sicinschi, Liviu A., P Corréa, Richard M. Peek, et al.. (2009). CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clinical Microbiology and Infection. 16(4). 369–378. 87 indexed citations

Yan, Fang, Hanwei Cao, Rupesh Chaturvedi, et al.. (2009). Epidermal Growth Factor Receptor Activation Protects Gastric Epithelial Cells From Helicobacter pylori-Induced Apoptosis. Gastroenterology. 136(4). 1297–1307.e3. 102 indexed citations

10.

Yamaoka, Toshimitsu, Yan Fang, Hanwei Cao, et al.. (2008). Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proceedings of the National Academy of Sciences. 105(33). 11772–11777. 91 indexed citations

11.

Moore, Sean R., Stuart Hobbs, Mark R. Frey, Richard L. Guerrant, & D. Brent Polk. (2008). S1661 Alanyl-Glutamine (Ala-Gln) Transactivates Epidermal Growth Factor Receptor (EGFR) to Stimulate Mitogen-Activated Protein Kinase (MAPK) Activity and Intestinal Epithelial Cell Growth. Gastroenterology. 134(4). A–244. 2 indexed citations

12.

Wilson, Kristy J., Christopher P. Mill, Elizabeth Cameron, et al.. (2007). Inter-conversion of neuregulin2 full and partial agonists for ErbB4. Biochemical and Biophysical Research Communications. 364(2). 351–357. 13 indexed citations

13.

Hobbs, Stuart, Richard L. Gallo, & David J. Riese. (2005). Phe45 of NRG2β is critical for the affinity of NRG2β for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2β. Growth Factors. 23(4). 273–283. 8 indexed citations

14.

Hobbs, Stuart, Elizabeth Cameron, Robert P. Hammer, et al.. (2003). Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase. Oncogene. 23(4). 883–893. 23 indexed citations

15.

Hobbs, Stuart, Stephanie L. Coffing, Elizabeth Cameron, et al.. (2002). Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene. 21(55). 8442–8452. 70 indexed citations

16.

Jones, Alison, et al.. (1990). Tumour necrosis factor, cholestatic jaundice, and chronic liver disease.. Gut. 31(8). 938–939. 43 indexed citations

17.

Selby, Peter J., Stuart Hobbs, C. Viner, et al.. (1987). Tumour necrosis factor in man: Clinical and biological observations. British Journal of Cancer. 56(6). 803–808. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact